当前位置: 首页 > 期刊 > 《健康之友.下半月》 > 201912
编号:13525963
美托洛尔治疗冠心病的临床疗效及药学研究
http://www.100md.com 2019年12月1日 《健康之友·下半月》 201912
心功能,心肌缺血缺氧
     【摘 要】目的:分析美托洛尔治疗冠心病的临床效果。方法:在我院收治的冠心病患者中选取62例,起止时间是2017年3月~2019年6月。分为2个小组:对照组31例,实施常规治疗;试验组31例,加用美托洛尔。评定临床疗效。结果:试验组总有效30例(96.8%),高于对照组的25例(80.6%);治疗后IVST、LVEF指标均优于对照组(P<0.05)。结论:美托洛尔治疗冠心病疗效确切,可以改善患者的心功能,值得推广。

    【关键词】冠心病;美托洛尔;心功能;心肌缺血缺氧

    【中图分类号】R541.4;R541.6 【文献识别码】B 【文章编号】1002-8714(2019)12-0006-01

    【abstract】 objective:to analyze the clinical effect of metoprolol in the treatment of coronary heart disease. Methods:a total of 62 CHD patients were selected from our hospital from March 2017 to June 2019. Divided into two groups:control group 31 cases conventional treatment; Metoprolol was added to 31 patients in the experimental group. Evaluate the clinical efficacy. Results30 cases (96.8%) were effective in the experimental group which was higher than 25 cases (80.6%) in the control group. After treatment IVST and LVEF indexes were better than those of the control group (P < 0.05). Conclusion:metoprolol is effective in treating coronary heart disease and can improve the cardiac function of patients. ......

您现在查看是摘要页,全文长 3861 字符